Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bilhvax vaccine for prevention of S. haematobium recurrence in children
NCT00870649Phase 3Completed
- Sponsor
- Inserm
- Start
- Feb 2009
- Primary completion
- Jun 2012
- Countries
- 1
01
Overview
A Phase 3 trial of rSh28GST in urinary schistosomiasis, sponsored by Inserm. Started Feb 2009; status: completed.
02
Drugs
rSh28GST
03
Conditions
urinary schistosomiasis
Beyond the preview
Go deeper on NCT00870649.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00870649.